Gideon Shapiro
Corporate Officer/Principal bei BRIGHT MINDS BIOSCIENCES INC.
Vermögen: 359 040 $ am 31.03.2024
Profil
Gideon Shapiro is the founder of Somatocor Pharmaceuticals, Inc., EraGen Biosciences, Inc. He is currently the Vice President-Discovery at Bright Minds Biosciences, Inc. He was previously the Chief Science Officer at Rugen Therapeutics and Vice President-Chemistry at FORUM Pharmaceuticals, Inc.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
22.12.2023 | 299 200 ( 6,93% ) | 359 040 $ | 31.03.2024 |
Aktive Positionen von Gideon Shapiro
Unternehmen | Position | Beginn |
---|---|---|
BRIGHT MINDS BIOSCIENCES INC. | Corporate Officer/Principal | 29.09.2020 |
Ehemalige bekannte Positionen von Gideon Shapiro
Unternehmen | Position | Ende |
---|---|---|
Rugen Therapeutics | Corporate Officer/Principal | 01.01.2019 |
Somatocor Pharmaceuticals, Inc. | Founder | - |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Corporate Officer/Principal | - |
EraGen Biosciences, Inc.
EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Chief Executive Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
EraGen Biosciences, Inc.
EraGen Biosciences, Inc. Medical SpecialtiesHealth Technology EraGen Biosciences, Inc. is a venture-backed biotechnology company. It designs, develops, manufactures and markets molecular diagnostic testing products and software for the research and clinical testing markets. The firm in-market and pipeline products, based on its novel, patented MultiCode platform chemistry, are the next generation of nucleic acid-based testing for the early detection and monitoring of cancer, genetic and infectious diseases. The company was founded in 1994 and is headquartered in Madison WI. | Health Technology |
Somatocor Pharmaceuticals, Inc. | |
Rugen Therapeutics |